305 Ill. Comp. Stat. § 5/5-30.1. Managed care protections: Medical Assistance – Illinois
Status: Enacted Year Enacted: 2014
An MCO shall pay any provider of emergency services that does not have in effect a contract with the contracted Medicaid MCO. The default rate of reimbursement shall be the rate paid under Illinois Medicaid […]
Download
A 1249 – New Jersey
Introduced: 2022 Status: In Process
The Governor’s Fiscal Year 2022 budget recommendations include the enactment of legislation to require the State Health Benefits Commission and School Employees’ Health Benefit Commission to implement a referenced based pricing program for certain elective […]
A 4305 (see companion bill S 220) – New Jersey
Introduced: 2018 Status: Inactive / Dead
SETS LEVEL FOR HEALTH CARE BENEFITS; REQUIRES EMPLOYEE CONTRIBUTIONS; PROHIBITS REIMBURSEMENT OF MEDICARE PART B; ADDS MEMBER TO SHBP/SEHBP PLAN DESIGN COMMITTEES; REQUIRES RETIREES TO PURCHASE HEALTH BENEFITS THROUGH EXCHANGES; PROVIDES SUBSIDES FOR OUT-OF-POCKET COSTS. […]
A 851 – New Jersey
Introduced: 2018 Status: Inactive / Dead
SETS LEVEL FOR HEALTH CARE BENEFITS; REQUIRES EMPLOYEE CONTRIBUTIONS; PROHIBITS REIMBURSEMENT OF MEDICARE PART B; ADDS MEMBER TO SHBP/SEHBP PLAN DESIGN COMMITTEES; REQUIRES RETIREES TO PURCHASE HEALTH CARE THROUGH EXCHANGES. Under the bill, all government […]
Ga. Code Ann. § 33-64-11. Prohibited activities of pharmacy benefits manager: Regulation and Licensure of Pharmacy Benefits Managers – Georgia
Status: Enacted Year Enacted: 2017
A pharmacy benefits manager shall be proscribed from prohibiting a pharmacist or pharmacy from providing an insured individual information on the amount of the insured’s cost share for such insured’s prescription drug and the clinical […]
Download
H 1154 – Massachusetts
Introduced: 2019 Status: Inactive / Dead
Relative to pharmacy benefit managers and pharmaceutical manufacturing companies. Health Care Financing.
H 1265 – Massachusetts
Introduced: 2021 Status: Inactive / Dead
Relative to the transparency and affordability of the Group Insurance Commission. Health Care Financing. There shall be a special commission governed by section 2A of chapter 4 of the General Laws to: (i) assess public […]
H 4653 – Massachusetts
Introduced: 2024 Status: Inactive / Dead
This bill aims to enhance the market review process for the Massachusetts health care system. The key provisions include: – Establishing a technical advisory committee within the Health Policy Commission to provide input on setting […]
H 735 – Vermont
Introduced: 2022 Status: Inactive / Dead
An act relating to considering using reference-based pricing for the State employees’ health plan. This bill proposes to direct the Department of Human Resources to convene a working group comprising representatives of the Department, labor […]
HB 1003 – Indiana
Introduced: 2023 Status: Inactive / Dead
Health matters. Allows a credit against the state tax liability of an employer with fewer than 50 employees if the employer has adopted a health reimbursement arrangement in lieu of a traditional employer provided health […]
HB 1004 – Indiana
Introduced: 2023 Status: Enacted
Establishes the health care cost oversight task force and sets forth duties of the task force. Provides a credit against state tax liability to certain physicians who have an ownership interest in a physician practice […]
HB 1501 – Florida
Introduced: 2022 Status: Inactive / Dead
Defines “reference-based pricing”; authorizes cost savings to be paid in cash to enrollee; requires certain contracted entities to use reference-based pricing program to set reimbursement rates.
HB 1655 – Washington
Introduced: 2025 Status: In Process
This bill addresses provider contract compensation by requiring health carriers to annually adjust compensation for healthcare providers not employed by hospitals or hospital affiliates, reflecting increases in the consumer price index (CPI). The legislation stems […]
HB 395 – Delaware
Introduced: 2024 Status: Inactive / Dead
This bill aims to amend Title 16 of the Delaware Code by setting new hospital cost containment measures. It specifically replaces a temporary measure previously tied to Medicare reference pricing, which is the cost of […]
HB 5431 (see companion bill SB 98) – Rhode Island
Introduced: 2023 Status: In Process
Prohibits the state, ERISA or any health plans to purchase referenced drugs for a cost higher than the referenced rate.
HB 5727 – Connecticut
Introduced: 2023 Status: Inactive / Dead
An Act concerning prescription drug costs. To provide that no prescription drug manufacturer may sell a prescription drug in this state at a price that exceeds such drug’s reference price.